logo

Alder Biopharmaceuticals Inc (ALDR)



Trade ALDR now with
  Date
  Headline
1/8/2018 8:26:04 AM Alder Enters European Patent Settlement And Global License Agreement With Teva Pharmaceuticals International GmbH
1/8/2018 7:44:06 AM Alder Says Eptinezumab Met Primary Endpoint In Its Pivotal Phase 3 PROMISE 2 Clinical Trial
6/27/2017 7:02:26 AM Alder BioPharma Announces Positive Eptinezumab Phase 3 Results For Prevention Of Frequent Episodic Migraine
11/28/2016 8:20:18 AM Alder BioPharmaceuticals Begins PROMISE 2 Pivotal Trial Of Eptinezumab For Prevention Of Migraine
9/15/2016 8:10:05 AM Alder BioPharma Presents Positive ALD403 Clinical Data At EHMTIC 2016